173 related articles for article (PubMed ID: 34210551)
1. Community-Based Assessment and Treatment of Hepatitis C Virus-Related Liver Disease, Injecting Drug and Alcohol Use Amongst People Who Are Homeless: A Systematic Review and Meta-Analysis.
Hashim A; Macken L; Jones A; McGeer M; Aithal G; Verma S
Int J Drug Policy; 2021 Oct; 96():103342. PubMed ID: 34210551
[TBL] [Abstract][Full Text] [Related]
2. Chronic liver disease in homeless individuals and performance of non-invasive liver fibrosis and injury markers: VALID study.
Hashim A; Bremner S; Grove JI; Astbury S; Mengozzi M; O'Sullivan M; Macken L; Worthley T; Katarey D; Aithal GP; Verma S
Liver Int; 2022 Mar; 42(3):628-639. PubMed ID: 34846794
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study.
Bajis S; Grebely J; Cooper L; Smith J; Owen G; Chudleigh A; Hajarizadeh B; Martinello M; Adey S; Read P; Gilliver R; Applegate T; Treloar C; Maher L; Dore GJ
J Viral Hepat; 2019 Aug; 26(8):969-979. PubMed ID: 30980785
[TBL] [Abstract][Full Text] [Related]
4. Factors Associated with Sustained Virologic Response to Hepatitis C Treatment in a Homeless-Experienced Cohort in Boston, 2014-2020.
Beiser ME; Shaw LC; Wilson GA; Muse KO; Shores SK; Baggett TP
J Gen Intern Med; 2023 Mar; 38(4):865-872. PubMed ID: 36127534
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis.
Hajarizadeh B; Cunningham EB; Valerio H; Martinello M; Law M; Janjua NZ; Midgard H; Dalgard O; Dillon J; Hickman M; Bruneau J; Dore GJ; Grebely J
J Hepatol; 2020 Apr; 72(4):643-657. PubMed ID: 31785345
[TBL] [Abstract][Full Text] [Related]
6. Low Hepatitis C Reinfection Following Direct-acting Antiviral Therapy Among People Who Inject Drugs on Opioid Agonist Therapy.
Akiyama MJ; Lipsey D; Heo M; Agyemang L; Norton BL; Hidalgo J; Lora K; Litwin AH
Clin Infect Dis; 2020 Jun; 70(12):2695-2702. PubMed ID: 31346609
[TBL] [Abstract][Full Text] [Related]
7. Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study.
Grebely J; Gilliver R; McNaughton T; Conway A; Cunningham E; Henderson C; Hadlow B; Molloy K; Doab A; Tillakeratne S; Pepolim L; Harrod ME; Dore GJ; Read P
Int J Drug Policy; 2023 Apr; 114():103982. PubMed ID: 36863287
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C Virus Reinfection in a Real-World Cohort of Homeless-Experienced Individuals in Boston.
Beiser ME; Shaw LC; Shores SK; Carson JM; Hajarizadeh B
Clin Infect Dis; 2023 Jul; 77(1):46-55. PubMed ID: 36869823
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus care cascade in persons experiencing homelessness in the United States in the era of direct-acting antiviral agents: A scoping review.
Del Rosario A; Eldredge JD; Doorley S; Mishra SI; Kesler D; Page K
J Viral Hepat; 2021 Nov; 28(11):1506-1514. PubMed ID: 34314081
[TBL] [Abstract][Full Text] [Related]
10. ITTREAT (Integrated Community Test - Stage - TREAT) Hepatitis C service for people who use drugs: Real-world outcomes.
O'Sullivan M; Jones AM; Gage H; Jordan J; MacPepple E; Williams H; Verma S
Liver Int; 2020 May; 40(5):1021-1031. PubMed ID: 32048798
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological interventions for acute hepatitis C infection.
Kalafateli M; Buzzetti E; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011644. PubMed ID: 30521693
[TBL] [Abstract][Full Text] [Related]
12. Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting.
Read P; Lothian R; Chronister K; Gilliver R; Kearley J; Dore GJ; van Beek I
Int J Drug Policy; 2017 Sep; 47():209-215. PubMed ID: 28587943
[TBL] [Abstract][Full Text] [Related]
13. Excellent hepatitis C virus cure rates despite increasing complexity of people who use drugs: Integrated-Test-stage Treat study final outcomes.
O'Sullivan M; Jones AM; Mourad A; Haddadin Y; Verma S
J Viral Hepat; 2024 Feb; 31(2):66-77. PubMed ID: 38018328
[TBL] [Abstract][Full Text] [Related]
14. A systematic review and meta-analysis of community and primary-care-based hepatitis C testing and treatment services that employ direct acting antiviral drug treatments.
Radley A; Robinson E; Aspinall EJ; Angus K; Tan L; Dillon JF
BMC Health Serv Res; 2019 Oct; 19(1):765. PubMed ID: 31660966
[TBL] [Abstract][Full Text] [Related]
15. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA
Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250
[TBL] [Abstract][Full Text] [Related]
16. Exploratory assessment: Nurse-led community health worker delivered HCV intervention for people experiencing homelessness.
Nyamathi A; Salem BE; Lee D; Yu Z; Hudson A; Saab S; Shin SS; Jones-Patten A; Yadav K; Alikhani M; Clarke R; Chang A; White K; Gelberg L
Public Health Nurs; 2023; 40(5):641-654. PubMed ID: 37132164
[TBL] [Abstract][Full Text] [Related]
17. Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis.
Cunningham EB; Wheeler A; Hajarizadeh B; French CE; Roche R; Marshall AD; Fontaine G; Conway A; Valencia BM; Bajis S; Presseau J; Ward JW; Degenhardt L; Dore GJ; Hickman M; Vickerman P; Grebely J
Lancet Gastroenterol Hepatol; 2022 May; 7(5):426-445. PubMed ID: 35303490
[TBL] [Abstract][Full Text] [Related]
18. Results of a Model of Delivering Hepatitis C Care in a Homeless Metropolitan Population in England.
Guerra-Veloz MF; Han K; Oakes K; Robertson D; Mohamed A; Cannon M; Barnabas A; Shah S; Halford R; Dusheiko G; Agarwal K
Am J Gastroenterol; 2023 Jun; 118(6):991-1000. PubMed ID: 36191276
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial for a peer-facilitated telemedicine hepatitis c treatment intervention for people who use drugs in rural communities: study protocol for the "peer tele-HCV" study.
Herink MC; Seaman A; Leichtling G; Larsen JE; Gailey T; Cook R; Thomas A; Korthuis PT
Addict Sci Clin Pract; 2023 May; 18(1):35. PubMed ID: 37245041
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C treatment outcomes among homeless-experienced individuals at a community health centre in Boston.
Beiser ME; Smith K; Ingemi M; Mulligan E; Baggett TP
Int J Drug Policy; 2019 Oct; 72():129-137. PubMed ID: 30962036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
